We identified previously an intracellular cobalamin 
chromatographed with N5-methyltetrahydrofolate:homocysteine methyltransferase activity (5-methyltetrahydropteroyl-L-glutamate:L-homocysteine S-methyltransferase, EC Cbl binding activity in rat liver can be accounted for by attachment of Cbl to the two known Cbl-dependent apoenzymes, methylmalonyl CoA mutase and methyltetrahydrofolate methyltransferase. The mechanism and significance of the observed binding protein deficiency in mutant human fibroblasts must, therefore, be re-evaluated. The mechanisms by which mammals sequester and utilize cobalamin (Cbl; vitamin B12) depend in part on the vitamin's interactions with specific binding proteins in extracellular fluids. In the gut, Cbl is complexed by the gastric glycoprotein "intrinsic factor," thus facilitating its transport to the circulation via a specific receptor located on the cell surface of the ileal enterocyte (1) . In the blood, newly absorbed (or parenterally administered) Cbl is bound by the specific serum protein transcobalamin II (TC II), a fl-globulin that greatly enhances cellular Cbl uptake due to the existence of a surface receptor for the TC II-Cbl complext (2) . Although the precise mode by which either of these receptor-mediated transport systems
operates has yet to be directly demonstrated, evidence is accumulating that TC II-Cbl is internalized intact via pinocytosis (3, 4) . Several (6) , HeLa cellst, and cultured human fibroblasts (7) . The fibroblast protein(s) chromatographs on Sephadex G-150 with an apparent molecular weight of 120,000, and is distinguished antigenically from the human serum Cbl binders known as "R" binders (8) , which have identical molecular weights on Sephadex. Furthermore, a large portion of the total intracellular Cbl appears to be bound by this protein(s) because over 90% of the cell radioactivity was associated with it after monolayers were exposed to [57Co]Cbl for 76 hr (7) .
The possible importance of this binding activity in the cell biology and metabolism of Cbl has been suggested by the finding that fibroblasts from patients expressing the cbl C mutation appear to lack it (7). These cells have abnormally low total Cbl content and are deficient in the synthesis of both Cbl coenzymes, deoxyadenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl) (9, 10 (11) and contained functional mutase and methyltransferase (9 (14) . The crude homogenate was first centrifuged for 1 min at 3000 X g to remove unbroken cells, nuclei, and tissue debris. The resulting supernatant ("whole homogenate") was then centrifuged for 2 min at 17,000 X g to pellet lysosomes and mitochondria. A lysosome-free mitochondrial fraction was prepared by incubating the 17,000 X g pellet with digitonin as described (13) . The 17,000 X g supernatant was centrifuged for 1 hr at 105,000 X g to prepare the microsomal and cytosolic fractions (14) . Column Chromatography. Sephadex G-150 was prepared according to Pharmacia, equilibrated in 0.05 M potassium phosphate (pH 7.4) containing 0.15 M NaCI, and poured into columns of 1.6 X 100 cm. The columns were standardized and run as described (7) except that samples were applied in volumes of 2-4 ml. The radioactivity in each fraction was determined with a Packard Auto-Gamma spectrometer. Subcellular fractions were prepared for chromatography as follows: the whole homogenate was sonicated at0°10 times for 20 sec each time and centrifuged for 1 hr at 105,000 X g; the supernatant was then applied to the column; the cytosol fraction was applied Samples containing up to 25 mg of protein were applied in volumes of up to 3 ml. The column was washed with 10 ml of starting buffer and the Cbl binders were eluted with a 100-ml linear salt gradient, followed by 20 (Fig. 1A) . The slight fall in the ratio of labeled cytosolic binder to mitochondrial binder observed bef S. Panichajakul and J. Bertino, unpublished data. Finally, two peaks of 57Co activity were resolved by polyacrylamide gel electrophoresis of the whole homogenate fraction (panel G). The first of these comigrated with mutase activity and, as before, was localized to the mitochondrial fraction (panel I); the second peak comigrated with methyltransferase activity, and was observed uniquely in the cytosolic fraction (panel HI).
Coenzyme Forms of Bound [57CoJCbl. If, as suggested by the results presented in Fig. 3 , the intracellular [57Co]Cbl binding proteins are in fact the Cbl-dependent enzymes methylmalonyl CoA mutase and methyltetrahydrofolate: homocysteine methyltransferase, then certain expectations arise regarding the coenzyme forms of Cbl bound to them. Therefore, the nature of the cobalamins bound to the cytosolic and mitochondrial proteins was determined. Cobalamins were extracted from the cytosolic and mitochondrial fractions at intervals after injection when 57Co activity was near maximal in that fraction (15 hr and 72 hr. respectively, see above). Because gel filtration profiles of the mitochondrial fraction revealed a minor but significant peak of free [57Co]Cbl, the supernatants of mitochondrial sonicates were filtered in the dark through a Sephadex G-25 column (2.5 X 25 cm) equilibrated in 20 mM Tris-HCl (pH 7.0) to separate protein-bound from free [57Co]-Cbl prior to extraction. As shown in Table 1 , the major [57Co]-Cbl species bound to protein in the mitochondrial fraction was AdoCbl. Although not shown, the free [57Co]Cbl isolated from this fraction contained an identical 57Co-labeled coenzyme profile. In contrast, the predominant species of [57CoICbl bound to the cytosolic binder was OH-Cbl. Furthermore, there was a significant amount of MeCbl (14%), which was not found on the mitochondrial protein. A small but detectable amount of radioactive AdoCbl (1.6%) was consistently observed. On the other hand, the cytosolic AdoCbl might be due to the putative existence of another AdoCbl-dependent enzyme, leucine 2,3-aminomutase, localized in this fraction (23) .
The kinetic data suggest that the tentatively identified mutase and methyltransferase may be involved in effecting the subcellular compartmental distribution of Cbl. After its ab- sorption by the liver, [57Co]Cbl is bound first (or more rapidly) by the cytosolic binder (Fig. 1B) . Eventually, however, [57Co]-Cbl appears to move to the mitochondrial compartment and to be bound by the mitochondrial binder (Fig. 2) . If this interpretation is correct, it is more likely that [57CoJCbl enters the mitochondria after dissociating from the methyltransferase rather than by a transport process mediated by the methyltransferase. Previous experiments have shown that isolated rat liver mitochondria will take up free Cbl at a rate far greater than that when Cbl is bound to the cytosol fraction's binder (21) . Thus, the subcellular distribution of Cbl might in part be regulated by the relative pool sizes and affinities of the two Cbldependent enzymes for Cbl. Finally, these results appear to have important consequences for the interpretation of recent data concerning the human cbl C phenotype (see above and refs. 7 and 9-11). Because preliminary results using normal human fibroblasts in culture have also suggested cochromatography of binding and enzyme activitiesO, our earlier suggestion that this disorder is caused by a deficiency of a unique binding protein species is highly improbable. Although a primary defect of methyltransferase and/or mutase that prevents binding of Cbl to both apoenzymes is a possibility, it seems more likely that the primary defect resides in some cellular process mediating the uptake, distribution, or metabolic conversion of Cbl such that the vitamin is not made available for binding by its apoenzymes.
After completion of this work, we learned that Kolhouse and Allen (24) 
